The use of serial patient blood gas, electrolyte and glucose results to derive biologic variation: A new tool to assess the acceptability of intensive care unit testing

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 10, 2010, Pages 1447-1454

  Cembrowski, George S ^a   Tran, David V ^a   Higgins, Trefor N ^b  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b DynaLIFE Dx   (Canada)

Author keywords

biologic variation; blood gas; electrolyte; glucose; intensive care unit

Indexed keywords

BICARBONATE; CHLORIDE ION; ELECTROLYTE; GLUCOSE; POTASSIUM ION; SODIUM ION;

ANALYTICAL ERROR; ANALYZER; ARTICLE; BLOOD GAS; BLOOD SAMPLING; CARBON DIOXIDE TENSION; CONTROLLED STUDY; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MEASUREMENT; OXYGEN TENSION; PH; PRIORITY JOURNAL; RELIABILITY;

BICARBONATES; BLOOD GAS ANALYSIS; BLOOD GLUCOSE; CARBON DIOXIDE; CHLORIDES; ELECTROLYTES; HUMANS; HYDROGEN-ION CONCENTRATION; INTENSIVE CARE UNITS; OXYGEN; POTASSIUM; SODIUM;

EID: 77958181146     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.286     Document Type: Article

References (35)

1. Ricós C, Iglesias N, García-Lario JV, Simón M, Cava F, Hernández A, et al. Within-subject biological variation in disease: collated data and clinical consequences. Ann Clin Biochem 2007;44:343-52.
2. Cotlove E, Harris EK, Williams GZ. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. 3. Physiological and medical implications. Clin Chem 1970;16:1028-32.
3. Fraser CG. Inherent biological variation and reference values. Clin Chem Lab Med 2004;42:758-64.
4. Fraser CG, Petersen PH, Libeer JC, Ricos C. Proposals for setting generally applicable quality goals solely based on biology. Ann Clin Biochem 1997;34:8-12.
5. Petersen PH, Fraser CG, Jorgensen L, Brandslund I, Stahl M, Gowans E, et al. Combination of analytical quality specifications based on biological within-and between-subject variation. Ann Clin Biochem 2002;39:543-50.
6. Biosca C, Ricos C, Jimenez CV, Lauzurica R, Galimany R. Are equally spaced specimen collections necessary to assess biological variation? Evidence from renal transplant recipients. Clin Chim Acta 2006;301:79-85.
7. Young DS, Harris EK, Cotlove E. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. IV. Results of a study designed to eliminate long-term analytic deviations. Clin Chem 1971;17:403-10.
8. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989;27:409-37.
9. 1c utilization. Am J Clin Path 2008;130:292-8.
10. Tran DV, Hofer TL, Lee T, Cembrowski GS. Unique approach to derivation of random error in laboratory assays: application to glycohemoglobin testing demonstrates poor clinical performance for immunochemistry assay. Diab Tech Ther 2003;5:975-8.
11. Tran DV, Cembrowski GS, Higgins TN. Use of 2 years of patient data to estimate intra-laboratory total imprecision of HbA (1c) measured by multiple HPLC analyzers. Clin Biochem 2008;41:177-9.
12. Tran DV, Lyon AW, Higgins TN, Wesenberg JC, Vandergouwe L, Wiley CL, et al. Use of serial patient hemoglobin A1c differences to determine long-term imprecision of immunoassay and high-performance liquid chromatography analyzers. J Diab SciTech 2009;3:424-8.
13. Garde AH, Hansen AM, Skovgaard LT, Christensen JM. Seasonal and biological variation of blood concentrations of total cholesterol, dehydroepiandrosterone sulfate, hemoglobin A1c, IgA, prolactin, and free testosterone in healthy women. Clin Chem 2000;46:551-9.
14. Rohlfing C, Wiedmeyer HM, Little R, Grotz VL, Tennill A, England J, et al. Biological variation of glycohemoglobin. Clin Chem 2002;48:1116-8.
15. Kolatkar NS, Cembrowski GS, Callahan PL, Etzwiler DD. Intensive diabetes management requires very precise testing of glycohemoglobin. Clin Chem 1994;40:1608-10.
16. Cembrowski GS: http://www.mylaboratoryquality.com/referenceintervals1x. htm, checked March 2010.
17. Cembrowski GS, Chandler EP, Westgard JO. Assessment of "average of normals" quality control procedures and guidelines for implementation. Am J Clin Path 1984;81:492-9.
18. Cembrowski GS, Carey RN. Laboratory quality management. Chicago IL: ASCP, 1989;14.
19. Ricos C, Alvarez A, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999;59:491-500.
20. Sebastian-Gambaro MA, Liron-Hernandez FJ, Fuentes-Arderiu X. Intra-and inter-individual biological variability data bank. Eur J Clin Chem Biochem 1997;35:845-52.
21. Eckfeldt JH, Chambless LE, Shen Y-L. Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study. Arch Pathol Lab Med 1994;118:496-500.
22. Fraser CG, Petersen PH. Analytical performance characteristics should be judged against objective quality specifications. Clin Chem 1999;45:321-3.
23. Reference manual for ABL800 FLEX, Radiometer Medical ApS, DK-2700 Brønshøj, Denmark, 2006.
24. Fraser CG. Biological variation in clinical chemistry. An update: collated data, 1988-1991. Arch Pathol Lab Med 1992;116:916-23.
25. Valenstein P, Schifman R. Duplicate testing. Arch Pathol Lab Med 1996;120:917-91.
26. Schoen C, Osborn R, Huynh PT, Doty M, Zapert K, Peugh J, et al. Taking the pulse of health care systems: experiences of patients with health problems in six countries. Health Affairs 2005;3:509-25.
27. Newman DH. Hippocrates' shadow, secrets from the house of medicine. Scribner: New York, NY, 2008:91-107 pp.
28. Lau M, Cembrowski GS, Journault L, Crawford J. IL GEM 3000 IQM does not detect clinically important shift in ionized calcium. Is it premature to suspend regular QC practices in the IL GEM series? Clin Chem 2007;53(Suppl. S): A178. Meeting Abstract.
29. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003;78:1471-8.
30. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-67.
31. Van den Berghe G, Bouillon R, Mesotten D, Braithwaite SS, Pei J, Yi D, et al. Glucose control in critically Ill patients. N Engl J Med 2009;361:89.
32. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. An evaluation of outcomes from intensive care in major medical centers. Ann Intern Med 1986;104:410-8.
33. Cembrowski GS, Blakney GB, Tran DV. Use of patient resultderived imprecisions to assess the analytic quality of electrolyte and creatinine measurements by Vitros and Beckman methodologies. Clin Chem 2009;55: (Suppl S) A215-6.
34. Cembrowski GS, Tran DV, Lyon AW. Tandem Roche Hitachi 917 and Tandem Beckman LX-20 operated in two tertiary care hospitals exhibit comparable patient-based imprecisions. Clin Chem 2009;55: (Suppl S) A34.
35. Ayres I. Super Crunchers, Bantam Dell, New York, NY, 2007.